← Back to Search

Other

HP-5000 Topical Patch for Osteoarthritis

Phase 1
Waitlist Available
Research Sponsored by Noven Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 21 days
Awards & highlights

Study Summary

This study is evaluating whether a patch may be a safe and effective way to deliver medication.

Eligible Conditions
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~21 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 21 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluating skin irritation with Mean Irritation Score (MIS)
Evaluating skin sensitization with the number and proportion of subjects sensitized using descriptive statistics

Trial Design

1Treatment groups
Experimental Treatment
Group I: HP-5000 Topical PatchExperimental Treatment3 Interventions
HP-5000, placebo and saline will be administered simultaneously.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HP-5000 Topical Patch
2021
Completed Phase 1
~200
HP-5000 Placebo Patch
2021
Completed Phase 1
~200
Saline Patch
2021
Completed Phase 1
~200

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Noven Pharmaceuticals, Inc.Lead Sponsor
8 Previous Clinical Trials
2,379 Total Patients Enrolled
2 Trials studying Osteoarthritis
659 Patients Enrolled for Osteoarthritis
Study DirectorStudy DirectorNoven Pharmaceuticals, Inc.
1,210 Previous Clinical Trials
489,289 Total Patients Enrolled
4 Trials studying Osteoarthritis
1,509 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Irritation and Sensitization Study of HP-5000 Topical System
2021. "Irritation and Sensitization Study of HP-5000 Topical System". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04882319.
~52 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top